Sartorius Stedim Biotech SA (DIM) — Strategic Asset Allocation Index
Sartorius Stedim Biotech SA (DIM) has a Strategic Asset Allocation Index of 59.5% as of September 2023. Strategic assets (PP&E of €1.56 Billion plus long-term investments of €-) total €1.56 Billion, measured against net assets of €2.63 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Sartorius Stedim Biotech SA balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Sartorius Stedim Biotech SA Strategic Asset Allocation Index (2013–2022)
This chart shows how Sartorius Stedim Biotech SA's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of September 2023, the index stands at 59.5%, representing strategic assets of €1.56 Billion against net assets of €2.63 Billion EUR. For live market cap and overall valuation, see Sartorius Stedim Biotech SA market capitalisation.
Annual Strategic Asset Allocation Index for Sartorius Stedim Biotech SA (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sartorius Stedim Biotech SA from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Sartorius Stedim Biotech SA for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 32.1% | €808.00 Million | €808.00 Million | €- | €2.51 Billion | ▼ -4.8 pp |
| 2021 | 36.9% | €640.24 Million | €640.24 Million | €- | €1.73 Billion | ▲ +2.0 pp |
| 2020 | 34.9% | €518.28 Million | €518.28 Million | €- | €1.48 Billion | ▼ -6.2 pp |
| 2019 | 41.2% | €485.17 Million | €470.09 Million | €15.08 Million | €1.18 Billion | ▲ +16.2 pp |
| 2018 | 25.0% | €260.90 Million | €255.26 Million | €5.64 Million | €1.04 Billion | ▼ -2.3 pp |
| 2017 | 27.3% | €239.92 Million | €228.12 Million | €11.81 Million | €879.45 Million | ▼ -2.5 pp |
| 2016 | 29.7% | €227.03 Million | €224.76 Million | €2.27 Million | €763.56 Million | ▼ -4.9 pp |
| 2015 | 34.6% | €224.21 Million | €222.88 Million | €1.33 Million | €647.22 Million | ▲ +3.5 pp |
| 2014 | 31.1% | €167.48 Million | €166.27 Million | €1.21 Million | €538.51 Million | ▼ -5.7 pp |
| 2013 | 36.8% | €177.16 Million | €175.86 Million | €1.30 Million | €481.84 Million | — |